We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

187 hedge funds and large institutions have $774M invested in AMAG Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 54

7% more funds holding

Funds holding: 174 → 187 (+13)

3% less capital invested

Capital invested by funds: $802M → $774M (-$28M)

76% less call options, than puts

Call options by funds: $3.87M | Put options by funds: $16.4M

Holders
187
Holders Change
+13
Holders Change %
+7.47%
% of All Funds
4.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
68
Reduced
54
Closed
20
Calls
$3.87M
Puts
$16.4M
Net Calls
-$12.5M
Net Calls Change
-$3.13M

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$17.7M
2
PP
PDT Partners
New York
+$5.47M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.45M
4
TAM
Tocqueville Asset Management
New York
+$4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.99M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$25.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$21.7M
3
GAM
Gotham Asset Management
New York
-$6.87M
4
State Street
State Street
Massachusetts
-$6.1M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
101
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$501K +$298 +16 +0.1%
SCM
102
Stevens Capital Management
Pennsylvania
$481K +$486K +26,084 New
State of Wisconsin Investment Board
103
State of Wisconsin Investment Board
Wisconsin
$480K – – –
TPSF
104
Texas Permanent School Fund
Texas
$475K +$3.26K +175 +0.7%
UBS Group
105
UBS Group
Switzerland
$453K -$644K -34,542 -58%
MLICM
106
Metropolitan Life Insurance Company (MetLife)
New York
$445K – – –
ProShare Advisors
107
ProShare Advisors
Maryland
$424K +$25.4K +1,364 +6%
TI
108
Trexquant Investment
Connecticut
$412K +$416K +22,322 New
Public Sector Pension Investment Board (PSP Investments)
109
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$403K +$76.8K +4,123 +23%
Thrivent Financial for Lutherans
110
Thrivent Financial for Lutherans
Minnesota
$397K +$8.2K +440 +2%
SAM
111
SignalPoint Asset Management
Missouri
$388K +$393K +21,072 New
O
112
OppenheimerFunds
New York
$375K -$116K -6,216 -23%
BCM
113
BlueCrest Capital Management
Jersey
$369K +$373K +20,016 New
DCM
114
Dupont Capital Management
Delaware
$364K +$186K +10,000 +103%
DTL
115
Dynamic Technology Lab
Singapore
$342K +$345K +18,528 New
ASRS
116
Arizona State Retirement System
Arizona
$338K – – –
DekaBank Deutsche Girozentrale
117
DekaBank Deutsche Girozentrale
Germany
$325K – – –
Allianz Asset Management
118
Allianz Asset Management
Germany
$323K -$2.09M -112,323 -87%
SEI Investments
119
SEI Investments
Pennsylvania
$291K +$93.1K +4,996 +46%
ED
120
Exane Derivatives
France
$284K -$104K -5,601 -27%
GC
121
Globeflex Capital
California
$284K +$122K +6,537 +74%
CCI
122
Credit Capital Investments
New Jersey
$277K – – –
New York State Teachers Retirement System (NYSTRS)
123
New York State Teachers Retirement System (NYSTRS)
New York
$277K +$1.86K +100 +0.7%
Macquarie Group
124
Macquarie Group
Australia
$266K +$268K +14,400 New
LSERS
125
Louisiana State Employees Retirement System
Louisiana
$264K – – –
3 4
5
6 7

AMAG Hedge Fund Activity: Q3 2017 in Review

187 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q3 2017, worth a combined $774M — down 3.5% from $802M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new AMAG positions and 20 closed out — a net gain of 15 holders — while 68 added to existing stakes and 54 trimmed.

The largest buyer was Camber Capital Management, adding an estimated $17.7M. The largest seller was Invesco, cutting an estimated $25.5M.

  • 187 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q3 2017, up from 174 in Q2 2017.
  • Funds reported $774M of AMAG Pharmaceuticals stock for Q3 2017, down 3.5% quarter-over-quarter.
  • 35 funds opened new AMAG Pharmaceuticals positions in Q3 2017 and 20 closed out, a net change of +15 holders.
  • The largest AMAG Pharmaceuticals buyer in Q3 2017 was Camber Capital Management, an estimated $17.7M added.
  • The largest AMAG Pharmaceuticals seller in Q3 2017 was Invesco, an estimated $25.5M sold.

Based on aggregated 13F filings for Q3 2017.